Neuraminidase Inhibitors Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuraminidase Inhibitors Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuraminidase Inhibitors Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuraminidase Inhibitors Drug Overall Market Size
2.1 Global Neuraminidase Inhibitors Drug Market Size: 2021 VS 2028
2.2 Global Neuraminidase Inhibitors Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuraminidase Inhibitors Drug Players in Global Market
3.2 Top Global Neuraminidase Inhibitors Drug Companies Ranked by Revenue
3.3 Global Neuraminidase Inhibitors Drug Revenue by Companies
3.4 Top 3 and Top 5 Neuraminidase Inhibitors Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neuraminidase Inhibitors Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuraminidase Inhibitors Drug Players in Global Market
3.6.1 List of Global Tier 1 Neuraminidase Inhibitors Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuraminidase Inhibitors Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Neuraminidase Inhibitors Drug Market Size Markets, 2021 & 2028
4.1.2 Oseltamivir
4.1.3 Zanamivir
4.1.4 Peramivir
4.1.5 Laninamivir
4.2 By Type - Global Neuraminidase Inhibitors Drug Revenue & Forecasts
4.2.1 By Type - Global Neuraminidase Inhibitors Drug Revenue, 2017-2022
4.2.2 By Type - Global Neuraminidase Inhibitors Drug Revenue, 2023-2028
4.2.3 By Type - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuraminidase Inhibitors Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Neuraminidase Inhibitors Drug Revenue & Forecasts
5.2.1 By Application - Global Neuraminidase Inhibitors Drug Revenue, 2017-2022
5.2.2 By Application - Global Neuraminidase Inhibitors Drug Revenue, 2023-2028
5.2.3 By Application - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Neuraminidase Inhibitors Drug Market Size, 2021 & 2028
6.2 By Region - Global Neuraminidase Inhibitors Drug Revenue & Forecasts
6.2.1 By Region - Global Neuraminidase Inhibitors Drug Revenue, 2017-2022
6.2.2 By Region - Global Neuraminidase Inhibitors Drug Revenue, 2023-2028
6.2.3 By Region - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Neuraminidase Inhibitors Drug Revenue, 2017-2028
6.3.2 US Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.3.3 Canada Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.3.4 Mexico Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Neuraminidase Inhibitors Drug Revenue, 2017-2028
6.4.2 Germany Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.3 France Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.4 U.K. Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.5 Italy Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.6 Russia Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.7 Nordic Countries Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.4.8 Benelux Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Neuraminidase Inhibitors Drug Revenue, 2017-2028
6.5.2 China Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.5.3 Japan Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.5.4 South Korea Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.5.5 Southeast Asia Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.5.6 India Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Neuraminidase Inhibitors Drug Revenue, 2017-2028
6.6.2 Brazil Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.6.3 Argentina Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuraminidase Inhibitors Drug Revenue, 2017-2028
6.7.2 Turkey Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.7.3 Israel Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Neuraminidase Inhibitors Drug Market Size, 2017-2028
6.7.5 UAE Neuraminidase Inhibitors Drug Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Neuraminidase Inhibitors Drug Major Product Offerings
7.1.4 Roche Neuraminidase Inhibitors Drug Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Neuraminidase Inhibitors Drug Major Product Offerings
7.2.4 GSK Neuraminidase Inhibitors Drug Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Gilead Sciences
7.3.1 Gilead Sciences Corporate Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Neuraminidase Inhibitors Drug Major Product Offerings
7.3.4 Gilead Sciences Neuraminidase Inhibitors Drug Revenue in Global Market (2017-2022)
7.3.5 Gilead Sciences Key News
7.4 Daiichi Sankyo
7.4.1 Daiichi Sankyo Corporate Summary
7.4.2 Daiichi Sankyo Business Overview
7.4.3 Daiichi Sankyo Neuraminidase Inhibitors Drug Major Product Offerings
7.4.4 Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue in Global Market (2017-2022)
7.4.5 Daiichi Sankyo Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuraminidase Inhibitors Drug Market Opportunities & Trends in Global Market
Table 2. Neuraminidase Inhibitors Drug Market Drivers in Global Market
Table 3. Neuraminidase Inhibitors Drug Market Restraints in Global Market
Table 4. Key Players of Neuraminidase Inhibitors Drug in Global Market
Table 5. Top Neuraminidase Inhibitors Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neuraminidase Inhibitors Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neuraminidase Inhibitors Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neuraminidase Inhibitors Drug Product Type
Table 9. List of Global Tier 1 Neuraminidase Inhibitors Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuraminidase Inhibitors Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neuraminidase Inhibitors Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neuraminidase Inhibitors Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neuraminidase Inhibitors Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neuraminidase Inhibitors Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neuraminidase Inhibitors Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neuraminidase Inhibitors Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Neuraminidase Inhibitors Drug Product Offerings
Table 32. Roche Neuraminidase Inhibitors Drug Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Neuraminidase Inhibitors Drug Product Offerings
Table 35. GSK Neuraminidase Inhibitors Drug Revenue (US$, Mn), (2017-2022)
Table 36. Gilead Sciences Corporate Summary
Table 37. Gilead Sciences Neuraminidase Inhibitors Drug Product Offerings
Table 38. Gilead Sciences Neuraminidase Inhibitors Drug Revenue (US$, Mn), (2017-2022)
Table 39. Daiichi Sankyo Corporate Summary
Table 40. Daiichi Sankyo Neuraminidase Inhibitors Drug Product Offerings
Table 41. Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Neuraminidase Inhibitors Drug Segment by Type in 2021
Figure 2. Neuraminidase Inhibitors Drug Segment by Application in 2021
Figure 3. Global Neuraminidase Inhibitors Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neuraminidase Inhibitors Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuraminidase Inhibitors Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuraminidase Inhibitors Drug Revenue in 2021
Figure 8. By Type - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 12. US Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 16. Germany Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 24. China Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neuraminidase Inhibitors Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neuraminidase Inhibitors Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Neuraminidase Inhibitors Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Neuraminidase Inhibitors Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Gilead Sciences Neuraminidase Inhibitors Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
